- Home
- AVDL vs MBC Comparison
AVDL vs MBC Comparison
Compare AVDL & MBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVDL
- MBC
- Stock Information
- Founded
- AVDL 2015
- MBC 1954
- Country
- AVDL Ireland
- MBC United States
- Employees
- AVDL N/A
- MBC N/A
- Industry
- AVDL Biotechnology: Pharmaceutical Preparations
- MBC Agricultural Chemicals
- Sector
- AVDL Health Care
- MBC Industrials
- Exchange
- AVDL Nasdaq
- MBC Nasdaq
- Market Cap
- AVDL 1.4B
- MBC 1.6B
- IPO Year
- AVDL 1996
- MBC N/A
- Fundamental
- Price
- AVDL $14.54
- MBC $12.72
- Analyst Decision
- AVDL Strong Buy
- MBC Strong Buy
- Analyst Count
- AVDL 7
- MBC 1
- Target Price
- AVDL $19.86
- MBC $15.00
- AVG Volume (30 Days)
- AVDL 1.4M
- MBC 1.9M
- Earning Date
- AVDL 08-07-2025
- MBC 08-06-2025
- Dividend Yield
- AVDL N/A
- MBC N/A
- EPS Growth
- AVDL N/A
- MBC N/A
- EPS
- AVDL N/A
- MBC 0.72
- Revenue
- AVDL $221,075,000.00
- MBC $2,777,000,000.00
- Revenue This Year
- AVDL $63.77
- MBC $0.13
- Revenue Next Year
- AVDL $29.91
- MBC $3.29
- P/E Ratio
- AVDL N/A
- MBC $17.60
- Revenue Growth
- AVDL 132.35
- MBC 4.05
- 52 Week Low
- AVDL $6.38
- MBC $9.63
- 52 Week High
- AVDL $16.66
- MBC $20.67
- Technical
- Relative Strength Index (RSI)
- AVDL 70.53
- MBC 55.15
- Support Level
- AVDL $14.52
- MBC $12.01
- Resistance Level
- AVDL $14.99
- MBC $13.36
- Average True Range (ATR)
- AVDL 0.53
- MBC 0.50
- MACD
- AVDL -0.00
- MBC -0.00
- Stochastic Oscillator
- AVDL 63.55
- MBC 58.84
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
About MBC MasterBrand Inc.
MasterBrand Inc operates as a residential cabinet manufacturer in North America. It offers a comprehensive portfolio of residential cabinetry products for the kitchen, bathroom, and other parts of the home. The firm sells its products throughout the United States and Canada through three primary channels: dealers, retailers and builders.